• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

Introduction to 3-Bromo-4-chloropyridine-5-methanol (CAS No. 1633014-12-6)

3-Bromo-4-chloropyridine-5-methanol is a versatile heterocyclic compound that has garnered significant attention in the field of pharmaceutical and chemical research due to its unique structural properties and potential applications. This compound, identified by the CAS number 1633014-12-6, features a pyridine core substituted with bromine, chlorine, and hydroxymethyl groups, making it a valuable intermediate in the synthesis of various biologically active molecules.

The structural configuration of 3-Bromo-4-chloropyridine-5-methanol allows for diverse functionalization, which is a critical factor in drug discovery and development. The presence of both bromine and chlorine atoms provides multiple sites for further chemical modifications, enabling the construction of complex molecular frameworks. These attributes make it an attractive building block for medicinal chemists seeking to develop novel therapeutic agents.

In recent years, there has been growing interest in exploring the pharmacological potential of pyridine derivatives. The methoxy group at the 5-position of the pyridine ring in 3-Bromo-4-chloropyridine-5-methanol contributes to its reactivity and can be utilized to introduce additional functional groups through various organic transformations. This flexibility has been leveraged in the synthesis of kinase inhibitors, anticancer agents, and other therapeutic compounds.

One of the most compelling aspects of 3-Bromo-4-chloropyridine-5-methanol is its role in the development of small-molecule drugs that target specific biological pathways. For instance, studies have demonstrated its utility in creating inhibitors of tyrosine kinases, which are implicated in various cancers and inflammatory diseases. The bromo and chloro substituents serve as handles for palladium-catalyzed cross-coupling reactions, allowing for the introduction of aryl or heteroaryl groups that can enhance binding affinity to biological targets.

Recent advancements in synthetic chemistry have further expanded the applications of 3-Bromo-4-chloropyridine-5-methanol. Transition-metal-catalyzed reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, have been particularly effective in incorporating diverse substituents into the pyridine scaffold. These methodologies have enabled the generation of structurally diverse libraries of compounds for high-throughput screening, facilitating the identification of lead candidates with improved pharmacokinetic profiles.

The compound's relevance extends beyond oncology; it has also been explored in the development of antimicrobial agents. The unique electronic properties conferred by the bromo and chloro substituents influence the compound's interactions with bacterial enzymes, making it a promising candidate for combating drug-resistant pathogens. Additionally, its ability to undergo selective modifications has allowed researchers to fine-tune its antimicrobial activity while minimizing toxicity.

In addition to its pharmaceutical applications, 3-Bromo-4-chloropyridine-5-methanol has found utility in materials science. Its ability to form coordination complexes with metal ions has been exploited in designing functional materials with applications ranging from catalysis to sensors. The hydroxymethyl group provides a site for chelation, enabling the creation of stable metal complexes that exhibit enhanced catalytic activity or luminescent properties.

The synthesis of 3-Bromo-4-chloropyridine-5-methanol typically involves multi-step organic transformations starting from commercially available pyridine derivatives. Key steps include halogenation at specific positions followed by functional group interconversion using appropriate reagents. Advances in synthetic methodologies have improved the efficiency and scalability of these processes, making it more feasible to produce this compound on an industrial scale.

Economic considerations also play a significant role in the adoption of 3-Bromo-4-chloropyridine-5-methanol as an intermediate. The cost-effectiveness of its synthesis and its availability from multiple suppliers have contributed to its widespread use in research and industrial settings. As demand grows for novel heterocyclic compounds, compounds like 3-Bromo-4-chloropyridine-5-methanol are expected to remain integral to drug discovery pipelines.

The environmental impact of producing and utilizing 3-Bromo-4-chloropyridine-5-methanol is another important consideration. Efforts are being made to develop greener synthetic routes that minimize waste and reduce energy consumption. These initiatives align with broader trends in sustainable chemistry aimed at reducing the ecological footprint of chemical manufacturing processes.

In conclusion,3-Bromo-4-chloropyridine-5-methanol (CAS No. 1633014-12-6) is a multifaceted compound with significant potential across multiple domains of chemical research and application. Its unique structural features make it a valuable intermediate for developing pharmaceuticals, materials, and functional chemicals. As synthetic methodologies continue to evolve, further opportunities are expected to emerge for leveraging this compound's versatility.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)